Methylcantharidin tablets
Function and Efficacy
This product is a derivative of cantharidin, which inhibits DNA synthesis of cancer cells and interferes with the M phase of cell division. Animal experiments show that this product has a certain inhibitory effect on mouse liver cancer and ascites cancer. At a blood concentration of 16-18.5 mg/ml, it can prolong the survival time of mice by 31%-103%. The LD50 of intravenous injection of this product is 375.2 mg/kg, and the LD50 of oral administration is 813.7 mg/kg.
Ingredients
Methylcantharidin
Appearance
This product is white tablets.
Indication
For primary liver cancer
Usage and Dosage
Oral administration. 5 to 10 tablets at a time, 3 to 4 times a day, 1 to 3 months as a course of treatment. The maximum dose is 20 to 40 tablets.
Adverse Reactions
There may be mild nausea and loss of appetite. There may also be reactions such as frequent urination, painful urination, and urgent urination.
Precautions
It is contraindicated for patients who are allergic to this product; it is contraindicated for patients with renal insufficiency.
Special Population Medication
Precautions for children: Use with caution in children. Precautions for pregnancy and lactation: Use with caution in pregnant and lactating women. Precautions for the elderly: Reduce the dosage if urinary system irritation symptoms occur.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
Keep sealed.
Packaging Specification
10mg
Validity Period
24 months
Manufacturer
Chongqing Yaoyanyuan Pharmaceutical Co., Ltd.
-
Founded in:
1986-11-13 -
Address:
No. 10, Bitong Road, Xinshi Street, Changshou District, Chongqing -
Tax NO.:
91500108202806395T -
Registered Funds:
28 million yuan -
Website:
-
Email: